Follicular Helper T Cells in Systemic Lupus Erythematosus: Why Should They Be Considered as Interesting Therapeutic Targets?

Journal of Immunology Research

Volumn 2016, Issue , 2016, Pages

  Sawaf, Matthieu ^a   Dumortier, Hélène ^a   Monneaux, Fanny ^a  

^a INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; CD28 ANTIGEN; CD40 LIGAND; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR5; INDUCIBLE T CELL COSTIMULATOR; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 21; INTERLEUKIN 21 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 6 RECEPTOR; MICRORNA; OX40 LIGAND; PROGRAMMED DEATH 1 LIGAND 1; PROTEIN; PROTEIN BTLA; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; UNCLASSIFIED DRUG; AUTOANTIBODY;

B LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; DENDRITIC CELL; HELPER CELL; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; LYMPHOCYTE MIGRATION; NONHUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); REGULATORY T LYMPHOCYTE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; ADULT; CELL DIFFERENTIATION; CYTOLOGY; GERMINAL CENTER; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOPHYSIOLOGY; PLASMA CELL;

ADULT; AUTOANTIBODIES; B-LYMPHOCYTES; CELL DIFFERENTIATION; GERMINAL CENTER; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MOLECULAR TARGETED THERAPY; PLASMA CELLS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84985940812     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2016/5767106     Document Type: Review

References (143)

1. M. R. Arbuckle, M. T. McClain, M. V. Rubertone et al., "Development of autoantibodies before the clinical onset of systemic lupus erythematosus," The New England Journal of Medicine, vol. 349, no. 16, pp. 1526-1533, 2003.
2. S. Lacotte, H. Dumortier, M. Décossas, J.-P. Briand, and S. Muller, "Identification of new pathogenic players in lupus: autoantibody-secreting cells are present in nephritic kidneys of (NZBxNZW)F1 mice," The Journal of Immunology, vol. 184, no. 7, pp. 3937-3945, 2010.
3. E. Arce, D.G. Jackson, M. A. Gill, L. B. Bennett, J. Banchereau, and V. Pascual, "Increased frequency of pre-germinal center b cells and plasma cell precursors in the blood of children with systemic lupus erythematosus," The Journal of Immunology, vol. 167, no. 4, pp. 2361-2369, 2001.
4. A. M. Jacobi, M. Odendahl, K. Reiter et al., "Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus," Arthritis & Rheumatism, vol. 48, no. 5, pp. 1332-1342, 2003.
5. C. T. Ravirajan, M. A. Rahman, L. Papadaki et al., "Genetic, structural and functional properties of an IgG DNA-binding monoclonal antibody from a lupus patient with nephritis," European Journal of Immunology, vol. 28, no. 1, pp. 339-350, 1998.
6. A. C. Grammer, R. Slota, R. Fischer et al., "Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions," The Journal of Clinical Investigation, vol. 112, no. 10, pp. 1506-1520, 2003.
7. C. G. Vinuesa, M. A. Linterman, D. Yu, and I. C.M. MacLennan, "Follicular helper T cells," Annual Review of Immunology, vol. 34, pp. 335-368, 2016.
8. S. Crotty, "Follicular helper CD4 T cells (TFH)," Annual Review of Immunology, vol. 29, pp. 621-663, 2011.
9. N. Fazilleau, L. J. McHeyzer-Williams, H. Rosen, and M. G. McHeyzer-Williams, "The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding," Nature Immunology, vol. 10, no. 4, pp. 375-384, 2009.
10. L. S. K. Walker, A. Gulbranson-Judge, S. Flynn et al., "Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXCchemokine receptor 5-positive CD4 cells and germinal centers," The Journal of Experimental Medicine, vol. 190, no. 8, pp. 1115-1122, 1999.
11. S. Fillatreau and D. Gray, "T cell accumulation in B cell follicles is regulated by dendritic cells and is independent of B cell activation," Journal of Experimental Medicine, vol. 197, no. 2, pp. 195-206, 2003.
12. Y. S. Choi, R. Kageyama, D. Eto et al., "ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6," Immunity, vol. 34, no. 6, pp. 932-946, 2011.
13. X. Liu, X. Chen, B. Zhong et al., "Transcription factor achaetescute homologue 2 initiates follicular T-helper-cell development," Nature, vol. 507, no. 7493, pp. 513-518, 2014.
14. F. Eddahri, S. Denanglaire, F. Bureau et al., "Interleukin- 6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities," Blood, vol. 113, no. 11, pp. 2426-2433, 2009.
15. N. Schmitt, R. Morita, L. Bourdery et al., "Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12," Immunity, vol. 31, no. 1, pp. 158-169, 2009.
16. FH) cell lineage is induced by IL-12," Immunology and Cell Biology, vol. 87, no. 8, pp. 590-600, 2009.
17. K.-M. Chavele, E. Merry, and M. R. Ehrenstein, "Circulating plasmablasts induce the differentiation of human T follicular helper cells via IL-6 production," Journal of Immunology, vol. 194, no. 6, pp. 2482-2485, 2015.
18. R. I. Nurieva, Y. Chung, D. Hwang et al., "Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages," Immunity, vol. 29, no. 1, pp. 138-149, 2008.
19. + T cells," The Journal of Experimental Medicine, vol. 206, no. 1, pp. 69-78, 2009.
20. R. Spolski and W. J. Leonard, "Interleukin-21: basic biology and implications for cancer and autoimmunity," Annual Review of Immunology, vol. 26, pp. 57-79, 2008.
21. P. C. Heinrich, I. Behrmann, S. Haan, H. M. Hermanns, G. Müller-Newen, and F. Schaper, "Principles of interleukin (IL)-6-type cytokine signalling and its regulation," Biochemical Journal, vol. 374, no. 1, pp. 1-20, 2003.
22. C. S. Ma, D. T. Avery, A. Chan et al., "Functional STAT3 deficiency compromises the generation of human T follicular helper cells," Blood, vol. 119, no. 17, pp. 3997-4008, 2012.
23. + T cells are decreased but partially functional in signal transducer and activator of transcription 3 deficiency," The Journal of Allergy and Clinical Immunology, vol. 131, no. 4, pp. 1146-1156, 2013.
24. R. J. Johnston, A. C. Poholek, D. Di Toro et al., "Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation," Science, vol. 325, no. 5943, pp. 1006-1010, 2009.
25. R. I. Nurieva, Y. Chung, G. J. Martinez et al., "Bcl6mediates the development of T follicular helper cells," Science, vol. 325, no. 5943, pp. 1001-1005, 2009.
26. D. Yu, S. Rao, L. M. Tsai et al., "The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment," Immunity, vol. 31, no. 3, pp. 457-468, 2009.
27. B. C. Betz, K. L. Jordan-Williams, C. Wang et al., "Batf coordinates multiple aspects of B and T cell function required for normal antibody responses," Journal of Experimental Medicine, vol. 207, no. 5, pp. 933-942, 2010.
28. Y. S. Choi, J. A. Gullicksrud, S. Xing et al., "LEF-1 and TCF-1 orchestrate T(HF) differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6," Nature Immunology, vol. 16, no. 9, pp. 980-990, 2015.
29. D. Stauss, C. Brunner, F. Berberich-Siebelt, U. E. Ho pken, M. Lipp, and G. Mu ller, "The transcriptional coactivator Bob1 promotes the development of follicular T helper cells via Bcl6," The EMBO Journal, vol. 35, no. 8, pp. 881-898, 2016.
30. E. L. Stone, M. Pepper, C. D. Katayama et al., "ICOS coreceptor signaling inactivates the transcription factor FOXO1 to promote Tfh cell differentiation," Immunity, vol. 42, no. 2, pp. 239-251, 2015.
31. S. M. Kerfoot, G. Yaari, J. R. Patel et al., "Germinal center B cell and T follicular helper cell development initiates in the interfollicular zone," Immunity, vol. 34, no. 6, pp. 947-960, 2011.
32. H. Qi, J. L. Cannons, F. Klauschen, P. L. Schwartzberg, and R. N. Germain, "SAP-controlled T-B cell interactions underlie germinal centre formation," Nature, vol. 455, no. 7214, pp. 764-769, 2008.
33. C. S. Ma, N. J. Hare, K. E. Nichols et al., "Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells," Journal of Clinical Investigation, vol. 115, no. 4, pp. 1049-1059, 2005.
34. L. V. Riella, A. M. Paterson, A. H. Sharpe, and A. Chandraker, "Role of the PD-1 pathway in the immune response," American Journal of Transplantation, vol. 12, no. 10, pp. 2575-2587, 2012.
35. A. L. Rankin, H. MacLeod, S. Keegan et al., "IL-21 receptor is critical for the development of memory B cell responses," Journal of Immunology, vol. 186, no. 2, pp. 667-674, 2011.
36. X. Ou, S. Xu, and K.-P. Lam, "Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival," Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 38, pp. 15401-15406, 2012.
37. R. Goenka, A. H. Matthews, B. Zhang et al., "Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation," The Journal of Experimental Medicine, vol. 211, no. 1, pp. 45-56, 2014.
38. E. Hams, M. J. McCarron, S. Amu et al., "Blockade of B7-H1 (programmed death ligand 1) enhances humoral immunity by positively regulating the generation of T follicular helper cells," The Journal of Immunology, vol. 186, no. 10, pp. 5648-5655, 2011.
39. D. Kashiwakuma, A. Suto, Y. Hiramatsu et al., "B and T lymphocyte attenuator suppresses IL-21 production from follicular Th cells and subsequent humoral immune responses," The Journal of Immunology, vol. 185, no. 5, pp. 2730-2736, 2010.
40. M. A. Linterman, W. Pierson, S. K. Lee et al., "Foxp3+ follicular regulatory T cells control the germinal center response," Nature Medicine, vol. 17, no. 8, pp. 975-982, 2011.
41. Y. Chung, S. Tanaka, F. Chu et al., "Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions," Nature Medicine, vol. 17, no. 8, pp. 983-988, 2011.
42. S. G. Kang, W.-H. Liu, P. Lu et al., "MicroRNAs of the miR-17~92 family are critical regulators of TFH differentiation," Nature Immunology, vol. 14, no. 8, pp. 849-857, 2013.
43. D. Baumjohann, R. Kageyama, J. M. Clingan et al., "The microRNA cluster miR-17~92 promotes TFH cell differentiation and represses subset-inappropriate gene expression," Nature Immunology, vol. 14, no. 8, pp. 840-848, 2013.
44. H. Takahashi, T. Kanno, S. Nakayamada et al., "TGF-β and retinoic acid induce the microRNA miR-10a, which targets Bcl-6 and constrains the plasticity of helper T cells," Nature Immunology, vol. 13, no. 6, pp. 587-595, 2012.
45. A. Pratama, M. Srivastava, N. J. Williams et al., "MicroRNA- 146a regulates ICOS-ICOSL signalling to limit accumulation of T follicular helper cells and germinal centres," Nature Communications, vol. 6, article 6436, 2015.
46. A. Ballesteros-Tato, B. León, B. A. Graf et al., "Interleukin- 2 inhibits germinal center formation by limiting T follicular helper cell differentiation," Immunity, vol. 36, no. 5, pp. 847-856, 2012.
47. R. J. Johnston, Y. S. Choi, J. A. Diamond, J. A. Yang, and S. Crotty, "STAT5 is a potent negative regulator of TFH cell differentiation," Journal of Experimental Medicine, vol. 209, no. 2, pp. 243-250, 2012.
48. R. I. Nurieva, A. Podd, Y. Chen et al., "STAT5 protein negatively regulates T follicular helper (Tfh) cell generation and function," The Journal of Biological Chemistry, vol. 287, no. 14, pp. 11234-11239, 2012.
49. FH-like gene profile," Nature Immunology, vol. 13, no. 4, pp. 405-411, 2012.
50. C. G. Vinuesa, M. C. Cook, C. Angelucci et al., "A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity," Nature, vol. 435, no. 7041, pp. 452-458, 2005.
51. M. A. Linterman, R. J. Rigby, R. K. Wong et al., "Follicular helper T cells are required for systemic autoimmunity," Journal of Experimental Medicine, vol. 206, no. 3, pp. 561-576, 2009.
52. K. Ozaki, R. Spolski, R. Ettinger et al., "Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6," The Journal of Immunology, vol. 173, no. 9, pp. 5361-5371, 2004.
53. J. A. Bubier, S. M. Bennett, T. J. Sproule et al., "Treatment of BXSB-Yaa mice with IL-21R-Fc fusion protein minimally attenuates systemic lupus erythematosus," Annals of the New York Academy of Sciences, vol. 1110, pp. 590-601, 2007.
54. D. Herber, T. P. Brown, S. Liang, D. A. Young, M. Collins, and K. Dunussi-Joannopoulos, "IL-21 has a pathogenic role in a lupusprone mouse model and its blockade with IL-21R. Fc reduces disease progression," The Journal of Immunology, vol. 178, no. 6, pp. 3822-3830, 2007.
55. A. L. Rankin, H. Guay, D. Herber et al., "IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas lpr/lpr/J mice," Journal of Immunology, vol. 188, no. 4, pp. 1656-1667, 2012.
56. J. A. Bubier, T. J. Sproule, O. Foreman et al., "A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 5, pp. 1518-1523, 2009.
57. J. M. Odegard, B. R. Marks, L. D. Diplacido et al., "ICOSdependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity," Journal of Experimental Medicine, vol. 205, no. 12, pp. 2873-2886, 2008.
58. J. William, C. Euler, S. Christensen, and M. J. Shlomchik, "Evolution of autoantibody responses via somatic hypermutation outside of germinal centers," Science, vol. 297, no. 5589, pp. 2066-2070, 2002.
59. N. Simpson, P. A. Gatenby, A. Wilson et al., "Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus," Arthritis and Rheumatism, vol. 62, no. 1, pp. 234-244, 2010.
60. J.-Y. Choi, J.H.-E. Ho, S. G. Pasoto et al., "Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity," Arthritis and Rheumatology, vol. 67, no. 4, pp. 988-999, 2015.
61. X. Feng, D. Wang, J. Chen et al., "Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus," PLoS ONE, vol. 7, no. 12, Article ID e51982, 2012.
62. +helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production," Lupus, vol. 24, no. 9, pp. 909-917, 2015.
63. H. Xu, J. Liu, X. Cui et al., "Increased frequency of circulating follicular helper T cells in lupus patients is associated with autoantibody production in a CD40L-dependent manner," Cellular Immunology, vol. 295, no. 1, pp. 46-51, 2015.
64. K. Szabó, G. Papp, A. Szántó, T. Tarr, and M. Zeher, "A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus," Clinical and Experimental Immunology, vol. 183, no. 1, pp. 76-89, 2016.
65. + T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion," Immunity, vol. 34, no. 1, pp. 108-121, 2011.
66. + TH cells correlates with antibody responses to influenza vaccination," Science Translational Medicine, vol. 5, no. 7, Article ID 176ra32, 2013.
67. J. He, L. M. Tsai, Y. Leong et al., "Circulating precursor CCR7loPD-1hi CXCR5+ CD4+ T cells indicate tfh cell activity and promote antibody responses upon antigen reexposure," Immunity, vol. 39, no. 4, pp. 770-781, 2013.
68. M. Locci, C. Havenar-Daughton, E. Landais et al., "Human circulating PD-1+CXCR3-CXCR5+memory Tfhcells are highly functional and correlate with broadly neutralizing HIV antibody responses," Immunity, vol. 39, no. 4, pp. 758-769, 2013.
69. C. Le Coz, A. Joublin, J.-L. Pasquali, A.-S. Korganow, H. Dumortier, and F. Monneaux, "Circulating TFH subset distribution is strongly affected in lupus patients with an active disease," PLoS ONE, vol. 8, no. 9, Article ID e75319, 2013.
70. G. C. Zeller, J. Hirahashi, A. Schwarting, A. H. Sharpe, and V. R. Kelley, "Inducible co-stimulator null MRL-Faslpr mice: uncoupling of autoantibodies and T cell responses in lupus," Journal of the American Society of Nephrology, vol. 17, no. 1, pp. 122-130, 2006.
71. Y.-J. Liu, D. E. Joshua, G. T. Williams, C. A. Smith, J. Gordon, and I. C. M. MacLennan, "Mechanism of antigen-driven selection in germinal centres," Nature, vol. 342, no.6252, pp.929-931, 1989.
72. A. Desai-Mehta, L. Lu, R. Ramsey-Goldman, and S. K. Datta, "Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production," Journal of Clinical Investigation, vol. 97, no. 9, pp. 2063-2073, 1996.
73. C. G. Katsiari, S.-N. C. Liossis, A. M. Dimopoulos, D. V. Charalambopoulos, M. Mavrikakis, and P. P. Sfikakis, "CD40L overexpression on T cells and monocytes from patients with systemic lupus erythematosus is resistant to calcineurin inhibition," Lupus, vol. 11, no. 6, pp. 370-378, 2002.
74. Y. Zhou, J. Yuan, Y. Pan et al., "T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus," Clinical Immunology, vol. 132, no. 3, pp. 362-370, 2009.
75. H. Xu, X. Li, D. Liu et al., "Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility," Nature, vol. 496, no. 7446, pp. 523-527, 2013.
76. D. Liu, H. Xu, C. Shih et al., "T-B-cell entanglement and ICOSLdriven feed-forward regulation of germinal centre reaction," Nature, vol. 517, no. 7533, pp. 214-218, 2015.
77. X.-N. Wu, Y.-X. Ye, J.-W. Niu et al., "Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus," Science Translational Medicine, vol. 6, no. 246, Article ID 246ra99, 2014.
78. J.-H. Yang, J. Zhang, Q. Cai et al., "Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus," Rheumatology, vol. 44, no. 10, pp. 1245-1254, 2005.
79. A. Hutloff, K. Büchner, K. Reiter et al., "Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus," Arthritis and Rheumatism, vol. 50, no. 10, pp. 3211-3220, 2004.
80. W.-X. Li, H.-F. Pan, G.-P. Chen, J.-H. Tao, X.-P. Li, and D.-Q. Ye, "Expression of inducible co-stimulator on peripheral blood T lymphocytes in patients with lupus nephritis," Rheumatology International, vol. 32, no. 7, pp. 2051-2055, 2012.
81. S. Patschan, S. Dolff, A. Kribben et al., "CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus," Clinical and Experimental Immunology, vol. 145, no. 2, pp. 235-242, 2006.
82. J. Aten, A. Roos, N. Claessen, E. J. M. Schilder-Tol, I. J. M. Ten Berge, and J. J. Weening, "Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis," Journal of the American Society of Nephrology, vol. 11, no. 8, pp. 1426-1438, 2000.
83. D. S. C. Graham, R. R. Graham, H. Manku et al., "Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus," Nature Genetics, vol. 40, no. 1, pp. 83-89, 2008.
84. C. Jacquemin, N. Schmitt, C. Contin-Bordes et al., "OX40 ligand contributes to human lupus pathogenesis by promoting T follicular helper response," Immunity, vol. 42, no. 6, pp. 1159-1170, 2015.
85. H.-Y. Chun, J.-W. Chung, H.-A. Kim et al., "Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus," Journal of Clinical Immunology, vol. 27, no. 5, pp. 461-466, 2007.
86. G. Gröndal, I. Gunnarsson, J. Rönnelid, S. Rogberg, L. Klareskog, and I. Lundberg, "Cytokine production, serumlevels and disease activity in systemic lupus erythematosus," Clinical and Experimental Rheumatology, vol. 18, no. 5, pp. 565-570, 2000.
87. Y. Horii, M. Iwano, E. Hirata et al., "Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis," Kidney International, vol. 39, pp. S71-S75, 1993.
88. P. Esposito, M. M. Balletta, A. Procino, L. Postiglione, and B. Memoli, "Interleukin-6 release from peripheral mononuclear cells is associated to disease activity and treatment response in patients with lupus nephritis," Lupus, vol. 18, no. 14, pp. 1329-1330, 2009.
89. M. De La Torre, J. M. Urra, and J. Blanco, "Raised expression of cytokine receptor gp130 subunit on peripheral lymphocytes of patients with active lupus. A useful tool for monitoring the disease activity?" Lupus, vol. 18, no. 3, pp. 216-222, 2009.
90. X.-F. Wang, S.-L. Yuan, L. Jiang et al., "Changes of serum BAFF and IL-21 levels in patients with systemic lupus erythematosus and their clinical significance," Xi Bao Yu Fen Mian Yi Xue Za Zhi, vol. 23, no. 11, pp. 1041-1042, 2007.
91. R. Caruso, E. Botti, M. Sarra et al., "Involvement of interleukin- 21 in the epidermal hyperplasia of psoriasis," Nature Medicine, vol. 15, no. 9, pp. 1013-1015, 2009.
92. S. Dolff, W.H. Abdulahad, J. Westra et al., "Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus," Arthritis Research & Therapy, vol. 13, no. 5, article R157, 2011.
93. R. Webb, J. T. Merrill, J. A. Kelly et al., "Apolymorphismwithin IL21R confers risk for systemic lupus erythematosus," Arthritis and Rheumatism, vol. 60, no. 8, pp. 2402-2407, 2009.
94. A. H. Sawalha, K. M. Kaufman, J. A. Kelly et al., "Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus," Annals of the Rheumatic Diseases, vol. 67, no. 4, pp. 458-461, 2008.
95. Y. Lan, B. Luo, J.-L. Wang, Y.-W. Jiang, and Y.-S. Wei, "The association of interleukin-21 polymorphisms with interleukin- 21 serumlevels and risk of systemic lupus erythematosus," Gene, vol. 538, no. 1, pp. 94-98, 2014.
96. J. Zhang, V. Roschke, K. P. Baker et al., "Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus," The Journal of Immunology, vol. 166, no. 1, pp. 6-10, 2001.
97. G. S. Cheema, V. Roschke, D. M. Hilbert, and W. Stohl, "Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases," Arthritis and Rheumatism, vol. 44, no. 6, pp. 1313-1319, 2001.
98. W. Stohl, S. Metyas, S.-M. Tan et al., "B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations," Arthritis & Rheumatism, vol. 48, no. 12, pp. 3475-3486, 2003.
99. M. Petri, W. Stohl, W. Chatham et al., "Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus," Arthritis and Rheumatism, vol. 58, no. 8, pp. 2453-2459, 2008.
100. M. Linker-Israeli, A. C. Bakke, R. C. Kitridou, S. Gendler, S. Gillis, and D. A. Horwitz, "Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE)," Journal of Immunology, vol. 130, no. 6, pp. 2651-2655, 1983.
101. L. A. Lieberman and G. C. Tsokos, "The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity," Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 740619, 6 pages, 2010.
102. E. E. Solomou, Y.-T. Juang, M. F. Gourley, G. M. Kammer, and G. C. Tsokos, "Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus," The Journal of Immunology, vol. 166, no. 6, pp. 4216-4222, 2001.
103. T. Harada, V. Kyttaris, Y. Li, Y.-T. Juang, Y. Wang, and G. C. Tsokos, "Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration," Autoimmunity, vol. 40, no. 1, pp. 1-8, 2007.
104. C.M. Hedrich, T. Rauen, S. A. Apostolidis et al., "Stat3 promotes IL-10 expression in lupus T cells through trans-activation and chromatin remodeling," Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 37, pp. 13457-13462, 2014.
105. Y. Tang, X. Luo, H. Cui et al., "MicroRNA-146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins," Arthritis and Rheumatism, vol. 60, no. 4, pp. 1065-1075, 2009.
106. J. B. Harley, M. E. Alarcón-Riquelme, L. A. Criswell et al., "Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci," Nature Genetics, vol. 40, no. 2, pp. 204-210, 2008.
107. S. E. Löfgren, J. Frostegård, L. Truedsson et al., "Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene," Genes & Immunity, vol. 13, no. 3, pp. 268-274, 2012.
108. M. Miyara, Z. Amoura, C. Parizot et al., "Global natural regulatory T cell depletion in active systemic lupus erythematosus," The Journal of Immunology, vol. 175, no. 12, pp. 8392-8400, 2005.
109. + T cells in peripheral blood of patients with systemic lupus erythematosus," Scandinavian Journal of Immunology, vol. 59, no. 2, pp. 198-202, 2004.
110. J. C. Crispin, A. Martínez, and J. Alcocer-Varela, "Quantification of regulatory T cells in patients with systemic lupus erythematosus," Journal of Autoimmunity, vol. 21, no. 3, pp. 273-276, 2003.
111. M. Bonelli, A. Savitskaya, K. von Dalwigk et al., "Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE)," International Immunology, vol. 20, no. 7, pp. 861-868, 2008.
112. X. Valencia, C. Yarboro, G. Illei, and P. E. Lipsky, "Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus," Journal of Immunology, vol. 178, no. 4, pp. 2579-2588, 2007.
113. -/lowregulatory T cells in patients with active systemic lupus erythematosus," Arthritis & Rheumatism, vol. 58, no. 7, pp. 2120-2130, 2008.
114. B. Yan, S. Ye, G. Chen, M. Kuang, N. Shen, and S. Chen, "Dysfunctional CD4+, CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon- α-producing antigen-presenting cells," Arthritis&Rheumatism, vol. 58, no. 3, pp. 801-812, 2008.
115. H. Iwai, M. Abe, S. Hirose et al., "Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis," Journal of Immunology, vol. 171, no. 6, pp. 2848-2854, 2003.
116. Y.-L. Hu, D. P. Metz, J. Chung, G. Siu, and M. Zhang, "B7RP- 1 blockade ameliorates autoimmunity through regulation of follicular helper T cells," The Journal of Immunology, vol. 182, no. 3, pp. 1421-1428, 2009.
117. J. Ma, J. Xu, M. P. Madaio et al., "Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses," Journal of Immunology, vol. 157, no. 1, pp. 417-426, 1996.
118. D. I. Daikh, B. K. Finck, P. S. Linsley, D. Hollenbaugh, and D. Wofsy, "Long-terminhibition ofmurine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways," The Journal of Immunology, vol. 159, no. 7, pp. 3104-3108, 1997.
119. B. A. Kiberd, "Interleukin-6 receptor blockage ameliorates murine lupus nephritis," Journal of the American Society of Nephrology, vol. 4, no. 1, pp. 58-61, 1993.
120. B. K. Finck, B. Chan, and D. Wofsy, "Interleukin 6 promotes murine lupus in NZB/NZW F1 mice," Journal of Clinical Investigation, vol. 94, no. 2, pp. 585-591, 1994.
121. 1 mice," Clinical and Experimental Immunology, vol. 112, no. 3, pp. 397-402, 1998.
122. J. A. Gross, J. Johnston, S. Mudri et al., "TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease," Nature, vol. 404, no. 6781, pp. 995-999, 2000.
123. M. Ramanujam, R. Bethunaickan, W. Huang, H. Tao, M. P. Madaio, and A. Davidson, "Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis in NZM2410 mice," Arthritis and Rheumatism, vol. 62, no. 5, pp. 1457-1468, 2010.
124. Y. Vugmeyster, H. Guay, P. Szklut et al., "In vitro potency, pharmacokinetic profiles, and pharmacological activity of optimized anti-IL-21R antibodies in a mouse model of lupus," mAbs, vol. 2, no. 3, pp. 335-346, 2010.
125. M. Zhang, G. Yu, B. Chan et al., "Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB × NZW)F1 systemic lupus erythematosus model," Arthritis & Rheumatology, vol. 67, no. 10, pp. 2723-2731, 2015.
126. Y. Pan, T. Jia, Y. Zhang et al., "MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupusprone mice," International Journal of Nanomedicine, vol. 7, pp. 5957-5967, 2012.
127. L. J. Edwards, M. Mizui, and V. Kyttaris, "Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL/lpr mice," Clinical Immunology, vol. 158, no. 2, pp. 221-230, 2015.
128. G. G. Illei, Y. Shirota, C. H. Yarboro et al., "Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact oncirculatingplasma cells fromanopen-label phase I dosage-escalation study," Arthritis and Rheumatism, vol. 62, no. 2, pp. 542-552, 2010.
129. S. V. Navarra, R. M. Guzmán, A. E. Gallacher et al., "Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial," The Lancet, vol. 377, no. 9767, pp. 721-731, 2011.
130. S. Flynn, K.-M. Toellner, C. Raykundalia, M. Goodall, and P. Lane, "CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1," The Journal of Experimental Medicine, vol. 188, no. 2, pp. 297-304, 1998.
131. T. Brocker, A. Gulbranson-Judge, S. Flynn, M. Riedinger, C. Raykundalia, and P. Lane, "CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles," European Journal of Immunology, vol. 29, no. 5, pp. 1610-1616, 1999.
132. M. Gigoux, J. Shang, Y. Pak et al., "Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3- kinase," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 48, pp. 20371-20376, 2009.
133. C. S. Ma, N. Wong, G. Rao et al., "Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficiencies," Journal of Allergy and Clinical Immunology, vol. 136, no. 4, pp. 993-1006, 2015.
134. D. Eto, C. Lao, D. Di Toro et al., "IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation," PLoS ONE, vol. 6, no. 3, Article ID e17739, 2011.
135. N. M. Haynes, C. D. C. Allen, R. Lesley, K. M. Ansel, N. Killeen, and J. G. Cyster, "Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1High germinal center-associated subpopulation," Journal of Immunology, vol. 179, no. 8, pp. 5099-5108, 2007.
136. D. Breitfeld, L. Ohl, E. Kremmer et al., "Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production," The Journal of Experimental Medicine, vol. 192, no. 11, pp. 1545-1551, 2000.
137. P. Schaerli, K. Willimann, A. B. Lang, M. Lipp, P. Loetscher, and B. Moser, "CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function," The Journal of Experimental Medicine, vol. 192, no. 11, pp. 1553-1562, 2000.
138. T. M. Foy, J. D. Laman, J. A. Ledbetter, A. Aruffo, E. Claassen, and R. J. Noelle, "gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory," The Journal of Experimental Medicine, vol. 180, no. 1, pp. 157-163, 1994.
139. S. Salek-Ardakani, Y. S. Choi, M. R.-E. Benhnia et al., "B cell-specific expression of B7-2 is required for follicular Th cell function in response to vaccinia virus," The Journal of Immunology, vol. 186, no. 9, pp. 5294-5303, 2011.
140. V. L. Bryant, C. S. Ma, D. T. Avery et al., "Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells," Journal of Immunology, vol. 179, no. 12, pp. 8180-8190, 2007.
141. R. L. Reinhardt, H.-E. Liang, and R. M. Locksley, "Cytokinesecreting follicular Tcells shape the antibody repertoire," Nature Immunology, vol. 10, no. 4, pp. 385-393, 2009.
142. I. Yusuf, R. Kageyama, L. Monticelli et al., "Germinal center T follicular helper cell IL-4 production is dependent on signaling lymphocytic activation molecule receptor (CD150)," Journal of Immunology, vol. 185, no. 1, pp. 190-202, 2010.
143. K. L. Good-Jacobson, C. G. Szumilas, L. Chen, A. H. Sharpe, M. M. Tomayko, and M. J. Shlomchik, "PD-1 regulates germinal center B cell survival and the formation and affinity of longlived plasma cells," Nature Immunology, vol. 11, no. 6, pp. 535-542, 2010.